Skip to content
Search

Latest Stories

Nearly 5 million Britons 'may miss European holidays for taking India-made AstraZeneca vaccine'

Nearly 5 million Britons 'may miss European holidays for taking India-made AstraZeneca vaccine'

AS MANY as five million Britons could remain locked out of their European holidays because the vaccine they took against Covid-19 is not recognised by the European Union’s passport scheme.

Millions of vaccines administered in the UK are yet to qualify for the EU’s vaccine passport scheme since they have been manufactured in India and the European Medicines Agency (EMA) has not yet authorised them, The Telegraph reported.


The situation could see several Britons getting rejected at EU border crossings once the batch numbers on their vaccines are checked digitally. The EU Digital Covid Certificate, which was launched on Thursday (1), is designed to make safe travel across the continent in times of the Covid-19 pandemic. It doesn’t recognise Covishield, the version of the AstraZeneca vaccine produced by the Serum Institute in India (SII) in Pune, Maharashtra, since it has not received approval in Europe yet.

The UK's health department has not revealed how many of the India-made vaccine doses have been administered in the UK, but the UK has seen nearly five million doses of this vaccine having been administered and they are identifiable by vaccine batch numbers (4120Z001, 4120Z002, 4120Z003) that are included on the recipients’ vaccine cards and in the Covid travel pass available via the UK’s NHS app, the report said.

The situation has already sparked an outrage in Asia and Africa where the Covishield, a key part of the COVAX initiative, has been widely used. Now, some British holidaymakers may also find themselves being left out.

‘I feel discriminated against’

The Telegraph contacted three such Britons and none of them had the prior information that they were to receive the Covishield jab. All of them got the Indian version of AstraZeneca in March. “Quite frankly [I feel] discriminated against,” said Hannah Smith, one of them aged 21.

Another individual, who chose not to be identified, said: “That vaccine passports would be a thing is entirely predictable, so our government should have made sure any they purchased would be recognised for travel everywhere.”

The EU Digital Covid Certificate allows those who are either fully vaccinated, recently tested or recovered from Covid-19 to cross borders within the EU without having to serve quarantine or undertake extra coronavirus tests upon arrival. But only vaccines approved by the EMA are included, though individual member states are free to accept other vaccines as well. Nine European countries have given approval for Covishield amid a tussle between India and the EU over ‘green pass’ for Covid vaccines.

The vaccines approved by EMA are Pfizer-BioNTech, Moderna, Johnson & Johnson, and the version of the Oxford-AstraZeneca vaccine made in the UK or Europe, is sold under the brand name Vaxzevria.

Covishield has not sought Europe license

According to The Telegraph report, there is no indication yet that the Indian-manufactured jab is substandard. The EMA has not authorised it only because the Indian makers have not yet sought a license for the product in Europe since the Indian firm manufacturing Covishield aims to predominantly supply to low- and middle-income countries.

Experts though feel that the issue is likely to be resolved if and when the EMA formally authorises Covishield jab in Europe.

Earlier this week, SII's chief executive officer Adar Poonawalla said on Wednesday (30) they were confident of getting approval from the EMA for Covishield. According to him, the issue of vaccine passports should be on the basis of reciprocity between countries.

“The EMA is absolutely correct in asking us to apply, which we have through AstraZeneca, our partners, a month ago, and that process has to take its time. An approval process even with UK MHRA, WHO took its time and we have applied to the EMA,” Poonawalla, who moved to London in May after allegedly facing threatening calls from powerful people in India, said at India Global Forum 2021.

More For You

AP Dhillon

From dropping beats to dropping jaws—AP Dhillon steals the show at Chanel in Paris

AP Dhillon owns the spotlight: From Brown Munde to Chanel’s front row in Paris

From selling out arenas to sitting front row at Chanel’s Paris Fashion Week show, the Punjabi rap superstar is moving in spaces once reserved for fashion’s elite. And he’s doing it with the same effortless swagger that made him a household name across South Asia and now, Europe.

AP Dhillon brings his signature style to Chanel’s front row

Keep ReadingShow less
NHS Greenlights New Daily Pill for Endometriosis Relief

This new pill can be taken at home

iStock

NHS approves new daily pill for endometriosis treatment in the UK

A new daily pill, relugolix-estradiol-norethisterone, designed to treat endometriosis, has been approved for use across England’s NHS. This medication provides a convenient and effective alternative to traditional treatments, offering relief for women suffering from this painful condition.

A Breakthrough in Endometriosis Care

Keep ReadingShow less
budget friendly spring destinations

Lock in affordable trips and avoid inflated prices

iStock

Top 7 budget-friendly spring destinations for 2025

With spring break just around the corner, it's time to lock in affordable trips and avoid inflated prices. Booking three weeks to a month in advance can help secure the best deals. Spring 2025 is shaping up to be a great time for travel, with airfares for international trips down by 3% and hotel rates decreasing by 2%, making it easier than ever to plan a memorable trip without breaking the bank. Here are seven top destinations to explore on a budget this spring.

1. Big Bear, California

Big Bear Lake, CaliforniaiStock

Keep ReadingShow less
slushies

Slushy drinks attract young children with their bright colours and taste

istock

Doctors urge children under 8 to avoid slushies due to glycerol risks

Children’s love for brightly coloured, sweet beverages, such as slushy ice drinks, may come with hidden dangers, according to new research that highlights the risks posed by glycerol, a common ingredient in these products. Doctors are now urging that children under eight should completely avoid slushy drinks that contain glycerol, as they may cause serious health issues, including loss of consciousness and shock.

The call for revised health advice comes in response to a recent study conducted by paediatricians in the UK and Ireland. The research, published in the journal Archives of Disease in Childhood, examined 21 cases of children aged between two and seven who required emergency treatment shortly after drinking glycerol-containing slushies. These cases, all from 2018 to 2024, involved children who became acutely ill within an hour of consuming the drinks.

Keep ReadingShow less
Naomi Watts Cheers as Daughter Kai Makes Debut at Paris Fashion Week

Kai made her runway debut at Paris Fashion Week

Instagram/ naomiwatts

Naomi Watts celebrates as daughter Kai makes stunning runway debut at Paris Fashion Week

Naomi Watts, the acclaimed British-Australian actress, has long been a fixture in Hollywood, known for her captivating performances in films like The Impossible and Mulholland Drive. But this week, it was her 16-year-old daughter, Kai Schreiber, who stole the spotlight. Kai made her runway debut at Paris Fashion Week, walking for the prestigious fashion house Valentino, and Naomi couldn’t have been prouder.

A star-studded debut

Kai’s debut on the Valentino catwalk was nothing short of spectacular. Dressed in a knit snakeskin mini dress with a dramatic feathered collar, the young model exuded confidence and elegance. The ensemble was completed with a beige headband, Havana sunglasses featuring blue lenses, white lace stockings, and matching sandals adorned with a rose strap. The look was bold, sophisticated, and perfectly suited to the high-fashion atmosphere of Paris Fashion Week.

Keep ReadingShow less